EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Post‐therapy plasma concentrations of quetiapine in Taiwanese patients

Cho-Yin Huang, Yen-Feng Lin, Chia-Ru Chen, Shih-Ku Lin iD

Neuropsychopharmacology Reports · 2023

DOI: 10.1002/npr2.12303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2023. Verfasst von Cho-Yin Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei City Hospital and Psychiatric Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Antipsychotic Agents, Psychotic Disorders. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taipei City Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Quetiapine is widely used to treat psychiatric disorders such as major depression, generalized anxiety disorder, dysthymic disorder, and insomnia other than schizophrenia and bipolar disorder. This study investigated the diagnostic distribution of quetiapine use in patients in a psychiatric hospital, the doses of quetiapine prescribed, and the plasma concentrations (Cps) of quetiapine and active metabolites.

Methods

We enrolled 107 patients who had been prescribed quetiapine for at least 4 weeks. Diagnoses, demographics, and concomitant medications were recorded. Blood sampling was performed in the morning, approximately 12 h after the before‐bed dose of quetiapine.

Results

Diagnoses comprised schizophrenia ( n = 25), bipolar disorder ( n = 51), major depression ( n = 15), dysthymic disorder ( n = 9), and others ( n = 7). The daily dose (DD) of quetiapine ranged from 25 to 800 (175.9 ± 184.4) mg, with the mean Cp being 105.6 ± 215.3 ng/ml, with a mean Cps/DD ratio of 0.58 ± 0.55 ng/ml/mg. There was a moderate positive linear correlation between the dose and Cps of quetiapine ( r = 0.60), and the interpatient variation in Cps/DD ratio was up to 26‐fold.

Conclusion

Quetiapine is used in various doses to treat many psychiatric disorders other than psychosis, and it is usually prescribed as a secondary antipsychotic for symptoms such as insomnia or agitation. A wide interpatient variation of the Cps/DD ratio was noticed. Patients of East Asian descent may exhibit a 50% to 100% increase in the Cps/DD ratio for quetiapine compared with patients of Western descent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersAntipsychotic AgentsPsychotic DisordersHumansQuetiapine FumarateDibenzothiazepines

Stichwörter der Autor:innen

bipolar disorderquetiapineracial differenceschizophreniatherapeutic drug monitoring

Substanzen

Quetiapine FumarateDibenzothiazepinesAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Taipei City Hospital and Psychiatric Center, Taipei, Taiwan.
  • Department of Psychiatry, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.

ORCID-Profile: Shih-Ku Lin

Förderung

  • Taipei City Government

Zitieren

APA

Huang, C. Y., Lin, Y. F., Chen, C. R., & Lin, S. K. (2023). Post‐therapy plasma concentrations of quetiapine in Taiwanese patients. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12303

Vancouver

Huang CY, Lin YF, Chen CR, Lin SK. Post‐therapy plasma concentrations of quetiapine in Taiwanese patients. Neuropsychopharmacology Reports. 2023. doi:10.1002/npr2.12303

BibTeX
@article{Huang2023,
  author = {Huang, Cho-Yin and Lin, Yen-Feng and Chen, Chia-Ru and Lin, Shih-Ku},
  title = {Post‐therapy plasma concentrations of quetiapine in Taiwanese patients},
  journal = {Neuropsychopharmacology Reports},
  year = {2023},
  doi = {10.1002/npr2.12303}
}
Kostenlos starten →